Strategies to improve recruitment to randomised trials

Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research. To quantify the effects of strategies for improving recruitment of participants to randomised trials. A secondary objective is to asse...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cochrane database of systematic reviews Ročník 2; s. MR000013
Hlavní autori: Treweek, Shaun, Pitkethly, Marie, Cook, Jonathan, Fraser, Cynthia, Mitchell, Elizabeth, Sullivan, Frank, Jackson, Catherine, Taskila, Tyna K, Gardner, Heidi
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 22.02.2018
Predmet:
ISSN:1469-493X, 1469-493X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research. To quantify the effects of strategies for improving recruitment of participants to randomised trials. A secondary objective is to assess the evidence for the effect of the research setting (e.g. primary care versus secondary care) on recruitment. We searched the Cochrane Methodology Review Group Specialised Register (CMR) in the Cochrane Library (July 2012, searched 11 February 2015); MEDLINE and MEDLINE In Process (OVID) (1946 to 10 February 2015); Embase (OVID) (1996 to 2015 Week 06); Science Citation Index & Social Science Citation Index (ISI) (2009 to 11 February 2015) and ERIC (EBSCO) (2009 to 11 February 2015). Randomised and quasi-randomised trials of methods to increase recruitment to randomised trials. This includes non-healthcare studies and studies recruiting to hypothetical trials. We excluded studies aiming to increase response rates to questionnaires or trial retention and those evaluating incentives and disincentives for clinicians to recruit participants. We extracted data on: the method evaluated; country in which the study was carried out; nature of the population; nature of the study setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each intervention group. We used a risk difference to estimate the absolute improvement and the 95% confidence interval (CI) to describe the effect in individual trials. We assessed heterogeneity between trial results. We used GRADE to judge the certainty we had in the evidence coming from each comparison. We identified 68 eligible trials (24 new to this update) with more than 74,000 participants. There were 63 studies involving interventions aimed directly at trial participants, while five evaluated interventions aimed at people recruiting participants. All studies were in health care.We found 72 comparisons, but just three are supported by high-certainty evidence according to GRADE.1. Open trials rather than blinded, placebo trials. The absolute improvement was 10% (95% CI 7% to 13%).2. Telephone reminders to people who do not respond to a postal invitation. The absolute improvement was 6% (95% CI 3% to 9%). This result applies to trials that have low underlying recruitment. We are less certain for trials that start out with moderately good recruitment (i.e. over 10%).3. Using a particular, bespoke, user-testing approach to develop participant information leaflets. This method involved spending a lot of time working with the target population for recruitment to decide on the content, format and appearance of the participant information leaflet. This made little or no difference to recruitment: absolute improvement was 1% (95% CI -1% to 3%).We had moderate-certainty evidence for eight other comparisons; our confidence was reduced for most of these because the results came from a single study. Three of the methods were changes to trial management, three were changes to how potential participants received information, one was aimed at recruiters, and the last was a test of financial incentives. All of these comparisons would benefit from other researchers replicating the evaluation. There were no evaluations in paediatric trials.We had much less confidence in the other 61 comparisons because the studies had design flaws, were single studies, had very uncertain results or were hypothetical (mock) trials rather than real ones. The literature on interventions to improve recruitment to trials has plenty of variety but little depth. Only 3 of 72 comparisons are supported by high-certainty evidence according to GRADE: having an open trial and using telephone reminders to non-responders to postal interventions both increase recruitment; a specialised way of developing participant information leaflets had little or no effect. The methodology research community should improve the evidence base by replicating evaluations of existing strategies, rather than developing and testing new ones.
AbstractList Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research. To quantify the effects of strategies for improving recruitment of participants to randomised trials. A secondary objective is to assess the evidence for the effect of the research setting (e.g. primary care versus secondary care) on recruitment. We searched the Cochrane Methodology Review Group Specialised Register (CMR) in the Cochrane Library (July 2012, searched 11 February 2015); MEDLINE and MEDLINE In Process (OVID) (1946 to 10 February 2015); Embase (OVID) (1996 to 2015 Week 06); Science Citation Index & Social Science Citation Index (ISI) (2009 to 11 February 2015) and ERIC (EBSCO) (2009 to 11 February 2015). Randomised and quasi-randomised trials of methods to increase recruitment to randomised trials. This includes non-healthcare studies and studies recruiting to hypothetical trials. We excluded studies aiming to increase response rates to questionnaires or trial retention and those evaluating incentives and disincentives for clinicians to recruit participants. We extracted data on: the method evaluated; country in which the study was carried out; nature of the population; nature of the study setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each intervention group. We used a risk difference to estimate the absolute improvement and the 95% confidence interval (CI) to describe the effect in individual trials. We assessed heterogeneity between trial results. We used GRADE to judge the certainty we had in the evidence coming from each comparison. We identified 68 eligible trials (24 new to this update) with more than 74,000 participants. There were 63 studies involving interventions aimed directly at trial participants, while five evaluated interventions aimed at people recruiting participants. All studies were in health care.We found 72 comparisons, but just three are supported by high-certainty evidence according to GRADE.1. Open trials rather than blinded, placebo trials. The absolute improvement was 10% (95% CI 7% to 13%).2. Telephone reminders to people who do not respond to a postal invitation. The absolute improvement was 6% (95% CI 3% to 9%). This result applies to trials that have low underlying recruitment. We are less certain for trials that start out with moderately good recruitment (i.e. over 10%).3. Using a particular, bespoke, user-testing approach to develop participant information leaflets. This method involved spending a lot of time working with the target population for recruitment to decide on the content, format and appearance of the participant information leaflet. This made little or no difference to recruitment: absolute improvement was 1% (95% CI -1% to 3%).We had moderate-certainty evidence for eight other comparisons; our confidence was reduced for most of these because the results came from a single study. Three of the methods were changes to trial management, three were changes to how potential participants received information, one was aimed at recruiters, and the last was a test of financial incentives. All of these comparisons would benefit from other researchers replicating the evaluation. There were no evaluations in paediatric trials.We had much less confidence in the other 61 comparisons because the studies had design flaws, were single studies, had very uncertain results or were hypothetical (mock) trials rather than real ones. The literature on interventions to improve recruitment to trials has plenty of variety but little depth. Only 3 of 72 comparisons are supported by high-certainty evidence according to GRADE: having an open trial and using telephone reminders to non-responders to postal interventions both increase recruitment; a specialised way of developing participant information leaflets had little or no effect. The methodology research community should improve the evidence base by replicating evaluations of existing strategies, rather than developing and testing new ones.
Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research.BACKGROUNDRecruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research.To quantify the effects of strategies for improving recruitment of participants to randomised trials. A secondary objective is to assess the evidence for the effect of the research setting (e.g. primary care versus secondary care) on recruitment.OBJECTIVESTo quantify the effects of strategies for improving recruitment of participants to randomised trials. A secondary objective is to assess the evidence for the effect of the research setting (e.g. primary care versus secondary care) on recruitment.We searched the Cochrane Methodology Review Group Specialised Register (CMR) in the Cochrane Library (July 2012, searched 11 February 2015); MEDLINE and MEDLINE In Process (OVID) (1946 to 10 February 2015); Embase (OVID) (1996 to 2015 Week 06); Science Citation Index & Social Science Citation Index (ISI) (2009 to 11 February 2015) and ERIC (EBSCO) (2009 to 11 February 2015).SEARCH METHODSWe searched the Cochrane Methodology Review Group Specialised Register (CMR) in the Cochrane Library (July 2012, searched 11 February 2015); MEDLINE and MEDLINE In Process (OVID) (1946 to 10 February 2015); Embase (OVID) (1996 to 2015 Week 06); Science Citation Index & Social Science Citation Index (ISI) (2009 to 11 February 2015) and ERIC (EBSCO) (2009 to 11 February 2015).Randomised and quasi-randomised trials of methods to increase recruitment to randomised trials. This includes non-healthcare studies and studies recruiting to hypothetical trials. We excluded studies aiming to increase response rates to questionnaires or trial retention and those evaluating incentives and disincentives for clinicians to recruit participants.SELECTION CRITERIARandomised and quasi-randomised trials of methods to increase recruitment to randomised trials. This includes non-healthcare studies and studies recruiting to hypothetical trials. We excluded studies aiming to increase response rates to questionnaires or trial retention and those evaluating incentives and disincentives for clinicians to recruit participants.We extracted data on: the method evaluated; country in which the study was carried out; nature of the population; nature of the study setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each intervention group. We used a risk difference to estimate the absolute improvement and the 95% confidence interval (CI) to describe the effect in individual trials. We assessed heterogeneity between trial results. We used GRADE to judge the certainty we had in the evidence coming from each comparison.DATA COLLECTION AND ANALYSISWe extracted data on: the method evaluated; country in which the study was carried out; nature of the population; nature of the study setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each intervention group. We used a risk difference to estimate the absolute improvement and the 95% confidence interval (CI) to describe the effect in individual trials. We assessed heterogeneity between trial results. We used GRADE to judge the certainty we had in the evidence coming from each comparison.We identified 68 eligible trials (24 new to this update) with more than 74,000 participants. There were 63 studies involving interventions aimed directly at trial participants, while five evaluated interventions aimed at people recruiting participants. All studies were in health care.We found 72 comparisons, but just three are supported by high-certainty evidence according to GRADE.1. Open trials rather than blinded, placebo trials. The absolute improvement was 10% (95% CI 7% to 13%).2. Telephone reminders to people who do not respond to a postal invitation. The absolute improvement was 6% (95% CI 3% to 9%). This result applies to trials that have low underlying recruitment. We are less certain for trials that start out with moderately good recruitment (i.e. over 10%).3. Using a particular, bespoke, user-testing approach to develop participant information leaflets. This method involved spending a lot of time working with the target population for recruitment to decide on the content, format and appearance of the participant information leaflet. This made little or no difference to recruitment: absolute improvement was 1% (95% CI -1% to 3%).We had moderate-certainty evidence for eight other comparisons; our confidence was reduced for most of these because the results came from a single study. Three of the methods were changes to trial management, three were changes to how potential participants received information, one was aimed at recruiters, and the last was a test of financial incentives. All of these comparisons would benefit from other researchers replicating the evaluation. There were no evaluations in paediatric trials.We had much less confidence in the other 61 comparisons because the studies had design flaws, were single studies, had very uncertain results or were hypothetical (mock) trials rather than real ones.MAIN RESULTSWe identified 68 eligible trials (24 new to this update) with more than 74,000 participants. There were 63 studies involving interventions aimed directly at trial participants, while five evaluated interventions aimed at people recruiting participants. All studies were in health care.We found 72 comparisons, but just three are supported by high-certainty evidence according to GRADE.1. Open trials rather than blinded, placebo trials. The absolute improvement was 10% (95% CI 7% to 13%).2. Telephone reminders to people who do not respond to a postal invitation. The absolute improvement was 6% (95% CI 3% to 9%). This result applies to trials that have low underlying recruitment. We are less certain for trials that start out with moderately good recruitment (i.e. over 10%).3. Using a particular, bespoke, user-testing approach to develop participant information leaflets. This method involved spending a lot of time working with the target population for recruitment to decide on the content, format and appearance of the participant information leaflet. This made little or no difference to recruitment: absolute improvement was 1% (95% CI -1% to 3%).We had moderate-certainty evidence for eight other comparisons; our confidence was reduced for most of these because the results came from a single study. Three of the methods were changes to trial management, three were changes to how potential participants received information, one was aimed at recruiters, and the last was a test of financial incentives. All of these comparisons would benefit from other researchers replicating the evaluation. There were no evaluations in paediatric trials.We had much less confidence in the other 61 comparisons because the studies had design flaws, were single studies, had very uncertain results or were hypothetical (mock) trials rather than real ones.The literature on interventions to improve recruitment to trials has plenty of variety but little depth. Only 3 of 72 comparisons are supported by high-certainty evidence according to GRADE: having an open trial and using telephone reminders to non-responders to postal interventions both increase recruitment; a specialised way of developing participant information leaflets had little or no effect. The methodology research community should improve the evidence base by replicating evaluations of existing strategies, rather than developing and testing new ones.AUTHORS' CONCLUSIONSThe literature on interventions to improve recruitment to trials has plenty of variety but little depth. Only 3 of 72 comparisons are supported by high-certainty evidence according to GRADE: having an open trial and using telephone reminders to non-responders to postal interventions both increase recruitment; a specialised way of developing participant information leaflets had little or no effect. The methodology research community should improve the evidence base by replicating evaluations of existing strategies, rather than developing and testing new ones.
Author Cook, Jonathan
Mitchell, Elizabeth
Fraser, Cynthia
Pitkethly, Marie
Taskila, Tyna K
Treweek, Shaun
Sullivan, Frank
Jackson, Catherine
Gardner, Heidi
Author_xml – sequence: 1
  givenname: Shaun
  surname: Treweek
  fullname: Treweek, Shaun
  organization: Health Services Research Unit, University of Aberdeen, Foresterhill, Aberdeen, UK, AB25 2ZD
– sequence: 2
  givenname: Marie
  surname: Pitkethly
  fullname: Pitkethly, Marie
– sequence: 3
  givenname: Jonathan
  surname: Cook
  fullname: Cook, Jonathan
– sequence: 4
  givenname: Cynthia
  surname: Fraser
  fullname: Fraser, Cynthia
– sequence: 5
  givenname: Elizabeth
  surname: Mitchell
  fullname: Mitchell, Elizabeth
– sequence: 6
  givenname: Frank
  surname: Sullivan
  fullname: Sullivan, Frank
– sequence: 7
  givenname: Catherine
  surname: Jackson
  fullname: Jackson, Catherine
– sequence: 8
  givenname: Tyna K
  surname: Taskila
  fullname: Taskila, Tyna K
– sequence: 9
  givenname: Heidi
  surname: Gardner
  fullname: Gardner, Heidi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29468635$$D View this record in MEDLINE/PubMed
BookMark eNpNj0lLxEAQhRsZcRb9C0OOXjJWL-lUH2VwgxHBBbyFTlKRyGSxuyP4721xBOvyHlUfj1dLNuuHnhhbc9hwAHHBlc44Zri5f4Q4XG7GqdRHbBEPJlVGvs7--Tlbev8OIA3neMLmwiiNWmYLpp-Cs4HeWvJJGJK2G93wSYmjyk1t6KgPP2tn-3roWk91Elxr9_6UHTdR6OygK_ZyffW8vU13Dzd328tdWqlc6pRyyLHR2JhMoUDktRECZQnCaGsNQIm5Qch1qbO6bipbqdJktpKR1cqiWLHz39xY62MiH4rYoqL93vY0TL4QALkSQkge0fUBncqO6mJ0bWfdV_H3q_gGEjxYpA
CitedBy_id crossref_primary_10_1186_s12874_024_02342_y
crossref_primary_10_1016_j_radi_2024_06_014
crossref_primary_10_12688_f1000research_24938_1
crossref_primary_10_3389_fpubh_2023_1123107
crossref_primary_10_1080_23311908_2024_2355779
crossref_primary_10_2196_30941
crossref_primary_10_1186_s13063_022_06818_4
crossref_primary_10_1136_bmjopen_2020_043929
crossref_primary_10_2147_PPA_S402769
crossref_primary_10_1186_s12875_022_01898_2
crossref_primary_10_1186_s13063_025_08958_9
crossref_primary_10_1016_j_jinf_2020_11_004
crossref_primary_10_12688_f1000research_19743_1
crossref_primary_10_1186_s13063_021_05043_9
crossref_primary_10_2196_18385
crossref_primary_10_1186_s13063_023_07504_9
crossref_primary_10_1186_s12877_022_03039_x
crossref_primary_10_1016_j_cct_2021_106399
crossref_primary_10_1136_bmjgh_2020_004145
crossref_primary_10_1177_17449871211068017
crossref_primary_10_1007_s12508_025_00450_8
crossref_primary_10_12688_f1000research_22182_1
crossref_primary_10_1177_26320843221106950
crossref_primary_10_1186_s13063_020_04358_3
crossref_primary_10_1186_s13063_025_08931_6
crossref_primary_10_1177_26320843221106949
crossref_primary_10_1177_14653125211024250
crossref_primary_10_1186_s40814_025_01658_w
crossref_primary_10_2196_24003
crossref_primary_10_1186_s13063_021_05346_x
crossref_primary_10_1186_s12916_023_02936_1
crossref_primary_10_1136_bmjopen_2023_078638
crossref_primary_10_2147_JMDH_S355055
crossref_primary_10_1080_23294515_2020_1775721
crossref_primary_10_1186_s13063_023_07727_w
crossref_primary_10_1177_08295735251340750
crossref_primary_10_1186_s12913_025_13115_8
crossref_primary_10_1001_jamanetworkopen_2023_33642
crossref_primary_10_1016_j_conctc_2019_100488
crossref_primary_10_1186_s12916_020_01555_4
crossref_primary_10_12688_f1000research_52164_1
crossref_primary_10_1016_j_jsat_2020_108259
crossref_primary_10_1186_s13063_021_05186_9
crossref_primary_10_12688_f1000research_52164_2
crossref_primary_10_1001_jama_2025_10107
crossref_primary_10_12688_f1000research_75339_1
crossref_primary_10_2196_58136
crossref_primary_10_1186_s13063_021_05624_8
crossref_primary_10_2196_resprot_9762
crossref_primary_10_1080_24709360_2018_1477467
crossref_primary_10_1186_s13063_025_08772_3
crossref_primary_10_1186_s13643_020_01471_x
crossref_primary_10_1002_cam4_7298
crossref_primary_10_1186_s13063_019_3496_z
crossref_primary_10_1177_15562646241309142
crossref_primary_10_7759_cureus_18920
crossref_primary_10_2196_63209
crossref_primary_10_1136_bmj_l6228
crossref_primary_10_1186_s13063_024_08301_8
crossref_primary_10_12688_f1000research_21902_1
crossref_primary_10_1186_s12998_022_00453_1
crossref_primary_10_3389_fpain_2023_1330937
crossref_primary_10_1002_eahr_500147
crossref_primary_10_1136_bmjopen_2021_048985
crossref_primary_10_1136_bmjopen_2022_064159
crossref_primary_10_1186_s13063_022_06052_y
crossref_primary_10_1186_s13643_023_02270_w
crossref_primary_10_1007_s40199_020_00380_7
crossref_primary_10_2196_29958
crossref_primary_10_1186_s13063_019_3273_z
crossref_primary_10_1136_archdischild_2020_319545
crossref_primary_10_12688_f1000research_24051_1
crossref_primary_10_12688_f1000research_130154_1
crossref_primary_10_1177_01939459231217919
crossref_primary_10_1016_j_profnurs_2024_12_010
crossref_primary_10_1136_leader_2022_000641
crossref_primary_10_1136_bmjopen_2021_059230
crossref_primary_10_3389_fneur_2019_00683
crossref_primary_10_3389_fpsyt_2021_647450
crossref_primary_10_2147_PRBM_S389562
crossref_primary_10_1038_s41598_024_57514_z
crossref_primary_10_1177_15579883211018418
crossref_primary_10_1136_bmjopen_2021_059194
crossref_primary_10_1136_bmjopen_2022_067656
crossref_primary_10_1136_bmjopen_2021_056758
crossref_primary_10_1186_s13063_021_05121_y
crossref_primary_10_3390_healthcare8040459
crossref_primary_10_1136_bmjopen_2023_078942
crossref_primary_10_1186_s12874_025_02464_x
crossref_primary_10_1186_s12913_025_12456_8
crossref_primary_10_1136_bmjopen_2021_054854
crossref_primary_10_3928_25731777_20230920_07
crossref_primary_10_1002_nop2_1767
crossref_primary_10_1002_cncr_34357
crossref_primary_10_1186_s12874_023_01838_3
crossref_primary_10_1186_s13063_022_06553_w
crossref_primary_10_1186_s12874_022_01553_5
crossref_primary_10_1136_bmjopen_2020_045233
crossref_primary_10_2147_AMEP_S485530
crossref_primary_10_1186_s13063_025_08824_8
crossref_primary_10_3390_jcm12062307
crossref_primary_10_1016_j_conctc_2020_100572
crossref_primary_10_2196_15455
crossref_primary_10_1186_s13063_025_08998_1
crossref_primary_10_1186_s12911_020_1091_6
crossref_primary_10_1016_j_ogla_2022_10_006
crossref_primary_10_1186_s13063_019_3980_5
crossref_primary_10_1136_bmjopen_2020_044702
crossref_primary_10_1186_s13063_021_05761_0
crossref_primary_10_1186_s12874_020_01140_6
crossref_primary_10_1186_s13063_023_07159_6
crossref_primary_10_12688_f1000research_18300_1
crossref_primary_10_1186_s13643_024_02533_0
crossref_primary_10_3389_fpubh_2022_983571
crossref_primary_10_1186_s13063_023_07268_2
crossref_primary_10_1186_s40900_021_00300_2
crossref_primary_10_2196_59027
crossref_primary_10_1016_j_ijmedinf_2023_104985
crossref_primary_10_1186_s13063_021_05818_0
crossref_primary_10_1371_journal_pone_0234783
crossref_primary_10_1186_s13063_021_05853_x
crossref_primary_10_1186_s13063_019_3710_z
crossref_primary_10_1136_bmj_2024_081660
crossref_primary_10_1111_pan_14755
crossref_primary_10_1136_bmj_m3721
crossref_primary_10_1186_s13063_021_05297_3
crossref_primary_10_1001_jamanetworkopen_2022_44040
crossref_primary_10_1136_bmjopen_2021_055521
crossref_primary_10_1177_08903344241297604
crossref_primary_10_1002_msc_1561
crossref_primary_10_1177_10748407231167438
crossref_primary_10_1002_cncr_35703
crossref_primary_10_1186_s13063_022_06705_y
crossref_primary_10_1186_s13063_024_08004_0
crossref_primary_10_1002_nop2_1027
crossref_primary_10_1186_s12966_020_01025_3
crossref_primary_10_1186_s13063_024_07988_z
crossref_primary_10_1186_s40900_022_00366_6
crossref_primary_10_1001_jama_2025_9170
crossref_primary_10_1186_s12874_020_01136_2
crossref_primary_10_1186_s13063_019_3354_z
crossref_primary_10_1177_15333175241276443
crossref_primary_10_12688_f1000research_110083_1
crossref_primary_10_1186_s40814_021_00866_4
crossref_primary_10_1186_s13063_025_08808_8
crossref_primary_10_2196_49347
crossref_primary_10_3390_ijerph17082764
crossref_primary_10_1186_s13063_023_07177_4
crossref_primary_10_12688_f1000research_18939_1
crossref_primary_10_3389_fphar_2020_603042
crossref_primary_10_1186_s13063_020_04234_0
crossref_primary_10_1186_s12916_023_03222_w
crossref_primary_10_1186_s13063_022_06187_y
crossref_primary_10_1002_eat_24187
crossref_primary_10_1186_s13063_020_04779_0
crossref_primary_10_1186_s13063_022_06588_z
crossref_primary_10_2196_29510
crossref_primary_10_2196_40892
crossref_primary_10_1186_s13063_024_08625_5
crossref_primary_10_1177_0193945919829145
crossref_primary_10_1186_s13063_023_07630_4
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/14651858.MR000013.pub6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1469-493X
ExternalDocumentID 29468635
Genre Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GrantInformation_xml – fundername: Chief Scientist Office
  grantid: HSRU1
– fundername: Medical Research Council
  grantid: MR/K025643/1
GroupedDBID ---
53G
5GY
7PX
9HA
ABJNI
ACGFO
ACGFS
AENEX
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AYR
CGR
CUY
CVF
D7G
ECM
EIF
HYE
NPM
OEC
OK1
P2P
RWY
WOW
ZYTZH
7X8
ID FETCH-LOGICAL-c4736-e7078f68f95482881d92283b0296aa900b8798076b65ddfcac4b95ac328864a82
IEDL.DBID 7X8
ISICitedReferencesCount 368
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000426476500033&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1469-493X
IngestDate Fri Jul 11 12:30:46 EDT 2025
Tue Jun 24 01:32:04 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4736-e7078f68f95482881d92283b0296aa900b8798076b65ddfcac4b95ac328864a82
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
OpenAccessLink https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000013.pub6/pdf/full
PMID 29468635
PQID 2007422231
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2007422231
pubmed_primary_29468635
PublicationCentury 2000
PublicationDate 2018-02-22
PublicationDateYYYYMMDD 2018-02-22
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-22
  day: 22
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Cochrane database of systematic reviews
PublicationTitleAlternate Cochrane Database Syst Rev
PublicationYear 2018
References 20393971 - Cochrane Database Syst Rev. 2010 Apr 14;(4):MR000013. doi: 10.1002/14651858.MR000013.pub5.
30586062 - Clin Orthop Relat Res. 2019 Jan;477(1):22-27. doi: 10.1097/CORR.0000000000000577.
References_xml – reference: 30586062 - Clin Orthop Relat Res. 2019 Jan;477(1):22-27. doi: 10.1097/CORR.0000000000000577.
– reference: 20393971 - Cochrane Database Syst Rev. 2010 Apr 14;(4):MR000013. doi: 10.1002/14651858.MR000013.pub5.
SSID ssj0039118
Score 2.6642632
SecondaryResourceType review_article
Snippet Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage MR000013
SubjectTerms Humans
Patient Education as Topic
Patient Selection
Randomized Controlled Trials as Topic
Reminder Systems
Sample Size
Telephone
Title Strategies to improve recruitment to randomised trials
URI https://www.ncbi.nlm.nih.gov/pubmed/29468635
https://www.proquest.com/docview/2007422231
Volume 2
WOSCitedRecordID wos000426476500033&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA7qiHhxX8aNCl7jdJI0TU4i4uBlhjko9Faywlxanc74-31JWz0JgpceSlOSl-S9j7d9CN0x5T3YIYOZlwQzqwwWOudYudRyrSyMSyPZRD6biaKQ887h1nRplb1OjIra1ib4yEfBpxbcFXT88P6BA2tUiK52FBqbaEAByoSUrrz4jiJQuMiirS4KTGq06CuEUzIaBw5wkYn7aWRcG9OwfP47zIzmZrL_34keoL0OaCaP7ck4RBuuOkI70y6Ufox435fWNcmqThbRueASUIDL9SKmnofXYMlsDUfB2STyezQn6G3y_Pr0gjsSBWxYTjl2oZ2P58KHzm5EADyVoeONTonkSsk01SKXIs255pm13ijDtMyUofAtZ0qQU7RV1ZU7R0mmtJeKCeoBEzhvJOynlZkw3MPvtBmi214iJcwsRB5U5ep1U_7IZIjOWrGW7203jZJIxgXAnos_jL5EuwBYRCwpJ1do4GHd7hptm8_VolnexN2H52w-_QJYrrk1
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Strategies+to+improve+recruitment+to+randomised+trials&rft.jtitle=Cochrane+database+of+systematic+reviews&rft.au=Treweek%2C+Shaun&rft.au=Pitkethly%2C+Marie&rft.au=Cook%2C+Jonathan&rft.au=Fraser%2C+Cynthia&rft.date=2018-02-22&rft.eissn=1469-493X&rft.volume=2&rft.spage=MR000013&rft_id=info:doi/10.1002%2F14651858.MR000013.pub6&rft_id=info%3Apmid%2F29468635&rft_id=info%3Apmid%2F29468635&rft.externalDocID=29468635
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1469-493X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1469-493X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1469-493X&client=summon